Emflaza
FDA Approves Drug to Treat Duchenne Muscular Dystrophy
Feb 10, 2017 at 08:10 am by Staff
On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dyst.... Read More